Detalhe da pesquisa
1.
Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
Gastroenterology
; 152(8): 1901-1914.e3, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193515
2.
Increases in Sex Hormones during Anti-Tumor Necrosis Factor α Therapy in Adolescents with Crohn's Disease.
J Pediatr
; 171: 146-52.e1-2, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26873656
3.
Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non-Small Cell Lung Cancer.
Clin Pharmacol Ther
; 115(3): 468-477, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776107
4.
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.
Lung Cancer
; 178: 166-171, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868177
5.
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial.
Nat Med
; 29(10): 2577-2585, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37710001
6.
Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation.
J Pediatr
; 160(1): 122-8, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21839468
7.
Association of chronic kidney disease with muscle deficits in children.
J Am Soc Nephrol
; 22(2): 377-86, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21115614
8.
Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease.
Gastroenterology
; 139(2): 430-8, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20417635
9.
Skeletal health of children and adolescents with inflammatory bowel disease.
J Pediatr Gastroenterol Nutr
; 53(1): 11-25, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21694532
10.
Circulating microRNA is a biomarker of pediatric Crohn disease.
J Pediatr Gastroenterol Nutr
; 53(1): 26-33, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21546856
11.
Daratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414).
JTO Clin Res Rep
; 2(2): 100104, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589982
12.
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.
J Clin Oncol
; 39(30): 3391-3402, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339292
13.
Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease.
Gastroenterology
; 136(1): 123-30, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19026647
14.
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC.
Cancer Discov
; 10(8): 1194-1209, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414908
15.
Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study.
Clin Gastroenterol Hepatol
; 6(12): 1378-84, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19081527
16.
Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease.
J Pediatr
; 153(4): 484-90, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18555484
17.
Increases in IGF-1 After Anti-TNF-α Therapy Are Associated With Bone and Muscle Accrual in Pediatric Crohn Disease.
J Clin Endocrinol Metab
; 103(3): 936-945, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29329430
18.
Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease.
Inflamm Bowel Dis
; 13(9): 1121-8, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17427245
19.
Serum Infliximab, Antidrug Antibodies, and Tumor Necrosis Factor Predict Sustained Response in Pediatric Crohn's Disease.
Inflamm Bowel Dis
; 22(6): 1370-7, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27057683
20.
Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's Disease.
J Clin Endocrinol Metab
; 100(7): 2630-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25919459